Latest Class Actions News

Lovisa Holdings reported a robust FY26 with revenue up 17.6% to A$938.8 million, expanded its global store network to 1,136 locations, and declared a 33 cent final dividend, reflecting strong momentum in key markets.

Shine Justice Ltd has taken a $13 million write down on a longstanding class action after an unexpected interlocutory judgment, cutting FY26 profit but leaving cash flow unaffected. Management plans to appeal and maintains confidence in the claim’s merits.

Arena REIT reported an 8% rise in net operating profit to $79.1 million for FY2026, driven by rental growth and development completions, while facing uncertainty over its Edge Early Learning Portfolio due to rent defaults.

Ovanti Limited has announced a complete global exit from the Buy Now Pay Later sector, ceasing all BNPL activities and shifting its focus to its established iSentric business in Southeast Asia, alongside significant cost reductions and imminent legal action against its former US BNPL CEO.

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.

Brambles Limited posted a 6% rise in sales revenue to US$7.04 billion for FY26, navigating US repair bottlenecks with decisive investments and reaffirming growth targets for FY27 and beyond.

Medibank Private Limited reported a 27.5% jump in net profit after tax to $638.7 million for FY26, driven by steady health insurance growth and a 31.3% surge in its Medibank Health segment. The company declared a fully franked final dividend of 10.9 cents per share and updated its Net Zero emissions strategy.

Evolution Mining delivered record FY26 profit and cash flow, declaring a 21-cent final dividend and setting a higher 60% payout policy while advancing key growth projects and acquisitions.

BHP Group Limited posted robust FY2026 results with a 15% revenue increase, record copper production contributing over half of underlying EBITDA, and a total fully franked dividend of 172 US cents per share. The company advances growth projects, including the Jansen potash mine, while managing legacy Samarco liabilities and pursuing climate targets.

EML Payments reported a 6% revenue decline and an 18% drop in underlying EBITDA for FY26, completing a major restructuring and advancing its Arlo technology platform. The company projects FY27 EBITDA between $50 million and $54 million, with a strong new program pipeline and strategic investments underpinning growth.

Australian Clinical Labs (ASX: ACL) delivered a modest 1.7% underlying EBIT increase in FY26, navigating subdued revenue and rising labour costs with operational efficiencies and strategic initiatives.

James Hardie Industries has been hit with a new class action in Victoria alleging breaches related to forward-looking financial statements made between May and August 2025. The company denies any wrongdoing and plans to defend vigorously.